Subtopic Deep Dive
Ex Vivo Lung Perfusion
Research Guide
What is Ex Vivo Lung Perfusion?
Ex vivo lung perfusion (EVLP) is a technique to assess and recondition marginal donor lungs outside the body prior to transplantation using normothermic perfusion protocols.
EVLP enables evaluation of high-risk donor lungs over 4 hours of perfusion, achieving outcomes comparable to standard lungs (Cypel et al., 2011, 1067 citations). Clinical trials like NCT01190059 demonstrated physiological stability during perfusion (Cypel et al., 2011). Registries track EVLP impacts on lung transplant volumes (Chambers et al., 2017, 1029 citations).
Why It Matters
EVLP expands the donor lung pool by rehabilitating marginal organs, addressing shortages noted in allocation systems (Egan et al., 2006, 753 citations). Cypel et al. (2011) showed transplanted EVLP lungs match conventional lung results, improving transplant rates. ISHLT registries report increased utilization of extended criteria donors via EVLP (Chambers et al., 2017; Khush et al., 2019). This reduces waitlist mortality in lung transplantation programs.
Key Research Challenges
Optimizing Perfusion Protocols
Standardizing normothermic perfusion duration and parameters remains inconsistent across centers (Cypel et al., 2011). Variability in lung stability during 4-hour EVLP affects predictability (Chambers et al., 2017). Registries highlight protocol differences impacting outcomes.
Predicting Post-Transplant Function
Assessing long-term allograft function after EVLP transplantation is limited by rejection risks (Verleden et al., 2019, 840 citations). Biomarkers for primary graft dysfunction post-EVLP need validation. ISHLT reports note ischemic time influences (Lund et al., 2017).
Integrating Therapeutic Interventions
Delivering therapies like mesenchymal stem cells during EVLP faces migration limitations (Eggenhofer et al., 2012, 779 citations). Lung-specific retention reduces systemic effects. Clinical translation requires efficacy trials.
Essential Papers
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Maria Rosa Costanzo, Maria Rosa Costanzo, Anne I. Dipchand et al. · 2010 · The Journal of Heart and Lung Transplantation · 1.6K citations
Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation
Marcelo Cypel, Jonathan Yeung, Mingyao Liu et al. · 2011 · New England Journal of Medicine · 1.1K citations
Transplantation of high-risk donor lungs that were physiologically stable during 4 hours of ex vivo perfusion led to results similar to those obtained with conventionally selected lungs. (Funded by...
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time
Daniel C. Chambers, Roger D. Yusen, Wida S. Cherikh et al. · 2017 · The Journal of Heart and Lung Transplantation · 1.0K citations
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019; focus theme: Donor and recipient size match
Kiran K. Khush, Wida S. Cherikh, Daniel C. Chambers et al. · 2019 · The Journal of Heart and Lung Transplantation · 894 citations
Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT
Geert M. Verleden, Allan R. Glanville, Erika D. Lease et al. · 2019 · The Journal of Heart and Lung Transplantation · 840 citations
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report—2017; Focus Theme: Allograft ischemic time
Lars H. Lund, Kiran K. Khush, Wida S. Cherikh et al. · 2017 · The Journal of Heart and Lung Transplantation · 788 citations
Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
Elke Eggenhofer, Volker Benseler, Alexander Kroemer et al. · 2012 · Frontiers in Immunology · 779 citations
Mesenchymal stem cells (MSC) are under investigation as a therapy for a variety of disorders. Although animal models show long term regenerative and immunomodulatory effects of MSC, the fate of MSC...
Reading Guide
Foundational Papers
Start with Cypel et al. (2011, 1067 citations) for clinical EVLP validation via 4-hour normothermic perfusion trial; then Costanzo et al. (2010, 1620 citations) for ISHLT transplant guidelines contextualizing lung care.
Recent Advances
Study Chambers et al. (2017, 1029 citations) and Khush et al. (2019, 894 citations) for registry data on EVLP-expanded donor pools and size matching.
Core Methods
Core techniques include normothermic EVLP for stability assessment (Cypel et al., 2011) and registry analysis of ischemic times (Lund et al., 2017).
How PapersFlow Helps You Research Ex Vivo Lung Perfusion
Discover & Search
Research Agent uses searchPapers and citationGraph to map EVLP literature from Cypel et al. (2011, 1067 citations), revealing connections to ISHLT registries like Chambers et al. (2017). exaSearch uncovers protocol variations; findSimilarPapers identifies related normothermic techniques.
Analyze & Verify
Analysis Agent applies readPaperContent to extract EVLP stability metrics from Cypel et al. (2011), then verifyResponse with CoVe checks claims against registries. runPythonAnalysis processes citation data for trends; GRADE grading evaluates evidence strength for clinical outcomes.
Synthesize & Write
Synthesis Agent detects gaps in EVLP long-term data via contradiction flagging across Verleden et al. (2019) and Cypel et al. (2011). Writing Agent uses latexEditText, latexSyncCitations, and latexCompile for transplant outcome reviews; exportMermaid visualizes perfusion protocol flows.
Use Cases
"Analyze survival rates from EVLP vs standard lung transplants in ISHLT data"
Research Agent → searchPapers(ISHLT EVLP) → Analysis Agent → runPythonAnalysis(pandas on survival metrics from Chambers 2017) → statistical p-values and GRADE-scored comparison table.
"Draft EVLP protocol review with citations and diagrams"
Synthesis Agent → gap detection(Cypel 2011 protocols) → Writing Agent → latexEditText(protocol LaTeX) → latexSyncCitations(ISHLT papers) → latexCompile → PDF with Mermaid perfusion flowchart.
"Find code for EVLP perfusion simulations"
Research Agent → paperExtractUrls(EVLP models) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable Python simulation scripts for lung stability modeling.
Automated Workflows
Deep Research workflow conducts systematic EVLP review: searchPapers(250+ normothermic perfusion papers) → citationGraph → DeepScan(7-step analysis with GRADE checkpoints) → structured report on outcomes. Theorizer generates hypotheses on EVLP therapies from Eggenhofer et al. (2012) stem cell data. DeepScan verifies protocol claims across Cypel (2011) and registries via CoVe.
Frequently Asked Questions
What is ex vivo lung perfusion?
EVLP perfuses marginal donor lungs normothermically outside the body to assess and repair them before transplantation (Cypel et al., 2011).
What are key EVLP methods?
Normothermic perfusion for 4 hours evaluates physiological stability, enabling high-risk lung use matching standard outcomes (Cypel et al., 2011, NCT01190059).
What are seminal EVLP papers?
Cypel et al. (2011, NEJM, 1067 citations) validated clinical EVLP; Chambers et al. (2017, 1029 citations) tracked registry impacts.
What are open problems in EVLP?
Standardizing protocols, predicting chronic dysfunction (Verleden et al., 2019), and optimizing interventions like stem cells (Eggenhofer et al., 2012) remain unresolved.
Research Transplantation: Methods and Outcomes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ex Vivo Lung Perfusion with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers